GlassScriptPhysician profile
David A Scheinberg
NPI 1871564633
$100,078.45
in general payments reported to CMS, 2019-2025
2 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $76K · 2020: $5,125 · 2021: $6,000 · 2022: $4,250 · 2023: $286 · 2024: $8,875.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,875 · Food and Beverage: $165 · Travel and Lodging: $120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,875.00 |
| Food and Beverage | $165.40 |
| Travel and Lodging | $120.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $70,613.63 | 2019 | |
| Pfizer INC. | $29,464.82 | 2019-2024 |
Research and ownership
$6,300.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Scheinberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.